We are live on ! Find out more
WST icon

West Pharmaceutical
WST

573 hedge funds and large institutions have $18.8B invested in West Pharmaceutical in 2020 Q3 according to their latest regulatory filings, with 101 funds opening new positions, 199 increasing their positions, 210 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more call options, than puts

Call options by funds: $20M | Put options by funds: $6.87M

110% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 48

19% more capital invested

Capital invested by funds: $15.8B → $18.8B (+$2.98B)

10% more funds holding

Funds holding: 523 → 573 (+50)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 210

1.26% less ownership

Funds ownership: 94.11% → 92.85% (-1.3%)

Holders
573
Holders Change
+50
Holders Change %
+9.56%
% of All Funds
11.56%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.18%
New
101
Increased
199
Reduced
210
Closed
48
Calls
$20M
Puts
$6.87M
Net Calls
+$13.1M
Net Calls Change
+$2.64M

Top Buyers

1
Invesco
Invesco
Georgia
+$123M
2
Goldman Sachs
Goldman Sachs
New York
+$114M
3
BlackRock
BlackRock
New York
+$70.7M
4
APG Asset Management
APG Asset Management
Netherlands
+$68.2M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$58.8M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$223M
2
JP Morgan Chase
JP Morgan Chase
New York
-$119M
3
Wells Fargo
Wells Fargo
California
-$55.3M
4
Bessemer Group
Bessemer Group
New Jersey
-$54.6M
5
WCM Investment Management
WCM Investment Management
California
-$49.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
RP
26
Riverbridge Partners
Minnesota
$162M -$4.62M -17,461 -3%
Legal & General Group
27
Legal & General Group
United Kingdom
$143M +$42M +158,555 +44%
Wells Fargo
28
Wells Fargo
California
$143M -$55.3M -209,090 -29%
Sumitomo Mitsui Trust Group
29
Sumitomo Mitsui Trust Group
Japan
$142M +$26M +98,139 +23%
CIP
30
Champlain Investment Partners
Vermont
$141M -$26.2M -98,865 -16%
1832 Asset Management
31
1832 Asset Management
Ontario, Canada
$133M +$17.3M +65,400 +16%
APG Asset Management
32
APG Asset Management
Netherlands
$120M +$68.2M +257,890 +102%
Charles Schwab
33
Charles Schwab
California
$119M -$43.7M -165,089 -28%
Federated Hermes
34
Federated Hermes
Pennsylvania
$119M -$12M -45,447 -10%
Prudential Financial
35
Prudential Financial
New Jersey
$114M +$12.9M +48,776 +13%
CAM
36
Congress Asset Management
Massachusetts
$114M -$275K -1,040 -0.3%
UBS AM
37
UBS AM
Illinois
$102M +$6.81M +25,746 +7%
JP Morgan Chase
38
JP Morgan Chase
New York
$98.9M -$119M -448,955 -55%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$95M -$238K -899 -0.3%
Ameriprise
40
Ameriprise
Minnesota
$93.2M +$14.4M +54,276 +19%
Schroder Investment Management Group
41
Schroder Investment Management Group
United Kingdom
$89.2M -$3.82M -14,424 -4%
UIM
42
USS Investment Management
United Kingdom
$87.9M – – –
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$86.7M -$12.9M -48,924 -13%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$86.7M -$3.93M -14,859 -4%
Fisher Asset Management
45
Fisher Asset Management
Washington
$86.6M -$29.8M -112,641 -26%
KBC Group
46
KBC Group
Belgium
$85.1M +$23.1M +87,248 +39%
Swiss National Bank
47
Swiss National Bank
Switzerland
$78.8M -$1.51M -5,700 -2%
Aberdeen Group
48
Aberdeen Group
United Kingdom
$76.6M +$1.34M +5,066 +2%
EAM
49
Eagle Asset Management
Florida
$73.4M -$900K -3,402 -1%
AAMU
50
Amundi Asset Management US
Massachusetts
$65.8M +$7.52M +28,408 +13%
1
2
3 4 5

WST Hedge Fund Activity: Q3 2020 in Review

573 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2020, worth a combined $18.8B — up 19% from $15.8B a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new WST positions and 48 closed out — a net gain of 53 holders — while 199 added to existing stakes and 210 trimmed.

The largest buyer was Invesco, adding an estimated $123M. The largest seller was T. Rowe Price Associates, cutting an estimated $223M.

  • 573 institutional investors held West Pharmaceutical (WST) as of Q3 2020, up from 523 in Q2 2020.
  • Funds reported $18.8B of West Pharmaceutical stock for Q3 2020, up 19% quarter-over-quarter.
  • 101 funds opened new West Pharmaceutical positions in Q3 2020 and 48 closed out, a net change of +53 holders.
  • The largest West Pharmaceutical buyer in Q3 2020 was Invesco, an estimated $123M added.
  • The largest West Pharmaceutical seller in Q3 2020 was T. Rowe Price Associates, an estimated $223M sold.

Based on aggregated 13F filings for Q3 2020.